Gambia

This fact sheet provides an overview of the MVP Access Program, an initiative that grants researchers access to data sets and frozen serum samples collected during the MenAfriVac ® clinical studies in Africa. The fact sheet outlines MenAfriVac's ® development history, qualified uses of data, and how to request data and/or serum access.

Perspectives from a mom, an immunization manager, and clinical investigators.

Two clinicians reflect on evaluating early vaccines in The Gambia

Perspectives from The Gambia’s immunization program manager

One mother’s story about enrolling her child in a vaccine trial.

PATH and its partners have been conducting clinical trials to evaluate a pneumococcal vaccine designed to meet needs in low-resource countries.

Mark Alderson won’t rest easy until he solves one of the biggest problems in global health: a vaccine against pneumonia.